CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.79B
1-Year Return
33.04%
This Quarter Return
-1.24%
1 Year Return
+33.04%
3 Year Return
+118.69%
5 Year Return
+239.8%
10 Year Return
–
AUM
$1.26B
AUM Growth
-$601M
(-32%)
Cap. Flow
-$550M
Cap. Flow
% of AUM
-43.78%
Top 10 Holdings %
Top 10 Hldgs %
21.47%
Holding
473
New
141
Increased
53
Reduced
88
Closed
177
Top Buys
| 1 |
Kinder Morgan
KMI
|
$29.5M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$25.2M |
| 3 |
Allegro MicroSystems
ALGM
|
$23.7M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$19.6M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$18.5M |
Top Sells
| 1 |
Antero Midstream
AM
|
$37.6M |
| 2 |
Williams Companies
WMB
|
$36.8M |
| 3 |
DFS
Discover Financial Services
DFS
|
$36.1M |
| 4 |
Duke Energy
DUK
|
$34.4M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$29.3M |
Sector Composition
| 1 | Financials | 16.29% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 15.48% |
| 4 | Technology | 14.9% |
| 5 | Utilities | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
351
DELISTED
Amedisys
AMED
| – | – |
-89,822
| Closed | -$8.15M |
|
352
Affiliated Managers Group
AMG
$6.55B
| – | – |
-17,328
| Closed | -$3.2M |
|
353
Amazon
AMZN
$2.49T
| – | – |
-59,552
| Closed | -$13.1M |
|
354
Apellis Pharmaceuticals
APLS
$3.56B
| – | – |
-86,991
| Closed | -$2.78M |
|
355
Aptiv
APTV
$17.5B
| – | – |
-81,361
| Closed | -$4.92M |
|
|
AVDL
356
Avadel Pharmaceuticals
AVDL
$1.49B
| – | – |
-69,458
| Closed | -$730K |
|
357
Avantor
AVTR
$9.11B
| – | – |
-75,330
| Closed | -$1.59M |
|
358
Axalta
AXTA
$6.87B
| – | – |
-52,436
| Closed | -$1.79M |
|
|
AZEK
359
DELISTED
The AZEK Co
AZEK
| – | – |
-17,100
| Closed | -$812K |
|
360
Boeing
BA
$172B
| – | – |
-60,859
| Closed | -$10.8M |
|
361
Brookfield Asset Management
BAM
$94B
| – | – |
-18,918
| Closed | -$1.03M |
|
362
Baxter International
BAX
$12.6B
| – | – |
-29,004
| Closed | -$846K |
|
363
BridgeBio Pharma
BBIO
$10.2B
| – | – |
-114,202
| Closed | -$3.13M |
|
364
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-194,386
| Closed | -$1.46M |
|
365
Becton Dickinson
BDX
$55B
| – | – |
-37,478
| Closed | -$8.5M |
|
366
Bloom Energy
BE
$13B
| – | – |
-599,009
| Closed | -$13.3M |
|
367
Beam Therapeutics
BEAM
$2.05B
| – | – |
-65,242
| Closed | -$1.62M |
|
368
Bausch + Lomb
BLCO
$5.28B
| – | – |
-96,696
| Closed | -$1.75M |
|
369
Capri Holdings
CPRI
$2.59B
| – | – |
-175,048
| Closed | -$3.69M |
|
370
Salesforce
CRM
$238B
| – | – |
-19,421
| Closed | -$6.49M |
|
371
Crinetics Pharmaceuticals
CRNX
$3.37B
| – | – |
-36,988
| Closed | -$1.89M |
|
372
Chevron
CVX
$312B
| – | – |
-30,154
| Closed | -$4.37M |
|
373
Curtiss-Wright
CW
$17.8B
| – | – |
-17,566
| Closed | -$6.23M |
|
374
Elanco Animal Health
ELAN
$9.01B
| – | – |
-51,788
| Closed | -$627K |
|
375
Element Solutions
ESI
$6.27B
| – | – |
-131,949
| Closed | -$3.36M |
|